DiscoverGoing anti-Viral
Going anti-Viral
Claim Ownership

Going anti-Viral

Author: Going Anti-Viral

Subscribed: 10Played: 290
Share

Description

Introducing Going anti-Viral, the podcast of the IAS–USA, a professional continuing medical education organization focused on HIV and other viral diseases. I’m Dr Michael Saag, professor emeritus of medicine and infectious diseases at the University of Alabama at Birmingham and volunteer member of the IAS–USA Board of Directors.  
Join us as we interview experts in viral medicine about their area of specialty and current developments in the field. Other episodes are drawn from the IAS-USA vast catalogue of panel discussions, Dialogues, and various meetings and conferences.  
Going anti-Viral is a podcast series for clinicians, produced by the International Antiviral Society–USA. The IAS–USA is a not-for-profit professional organization committed to improving the treatment, care, and quality of life for people with or at risk for HIV or other viral infections and their complications through balanced education and information. This podcast is intended as a clinical source of information for specialists in this field, but we hope anyone listening will enjoy learning more about the state of modern medicine around viral infections and their consequences.

88 Episodes
Reverse
In episode 87 of Going anti-Viral, we represent a panel discussion from September 3, 2026, as part of the IAS–USA Dialogue series Emerging Infections and Health Threats. This Dialogue is a must listen as our distinguished panel of infectious disease experts dives deep into some of the most pressing public health challenges facing the world today. Moderated by Carlos del Rio, MD, a Distinguished Professor of Medicine in the Division of Infectious Diseases at Emory University School of Medicine...
In episode 86 of Going anti-Viral, Dr Brenda Crabtree-Ramírez joins host Dr Michael Saag to discuss women and HIV in Latin America. Dr Crabtree-Ramírez is a Professor of the HIV Program at the Universidad Nacional Autónoma de México. She has participated in Phase I to IV clinical trials evaluating therapies for HIV/AIDS and opportunistic infections and is the Principal Investigator in Mexico for the Caribbean, Central, and South America Network for HIV Epidemiology (CCASAnet). She has contrib...
In episode 85 of Going anti-Viral, Dr Andrea Gramatica joins host Dr Michael Saag to discuss the work of amfAR and how HIV research drives breakthroughs for other diseases. Dr Gramatica is Vice President of Research at amfAR and an expert in immunology and HIV virology with a research focus on viral persistence and immune modulation. Dr Gramatica is responsible for shaping the strategic direction of amfAR’s research programs, including building upon existing research into HIV and other viral ...
In episode 84 of Going anti-Viral, Nicholas Enrich joins host Dr Michael Saag to discuss his book Into the Wood Chipper: A Whistleblower's Account of How the Trump Administration Shredded USAID. Mr Enrich is a former civil servant who worked at the United States Agency for International Development (USAID) under 4 administrations. He served as the Bureau of Global Health director of policy, programs, and planning until January 2025, when he was designated as the USAID acting assistant adminis...
In episode 83 of Going anti-Viral, Dr Steven Grinspoon joins host Dr Michael Saag to provide an update on guidelines for statin use in people with HIV based on results from the REPRIEVE trial. Dr Grinspoon is a Professor of Medicine at Harvard Medical School and a clinician in the Neuroendocrine and Pituitary Tumor Clinical Center and faculty member at the Massachusetts General Hospital. He is a clinical researcher who studies hypothalamic control of body weight and fat distribution in obesit...
loading
Comments